News about Market

Crane NXT to Acquire Antares Vision, Plans Take-Private Deal

Crane NXT, a leading industrial technology company, announced that it has signed definitive agreements to acquire a significant stake in Antares Vision S.p.A., with plans to take the company private.

Market | 28/11/2025 | By Darshana |  140

Eris Lifesciences to Increase Its Stake in Swiss Parenterals

Eris Lifesciences has announced plans to consolidate its stake in Swiss Parenterals, while bringing Naishadh Shah on board as a top-10 shareholder and part of the management, strengthening its leadership and long-term strategic vision.

Market | 27/11/2025 | By Dineshwori |  119

Revvity to Acquire ACD/Labs to Strengthen Scientific Software Portfolio

Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software that supports analytical characterization and molecular design for pharmaceutical and material sciences.

Market | 25/11/2025 | By Darshana |  242

Aurobindo Pharma's China Facility Running at Loss, Eyes Break-Even by Q4

The company’s CFO, S. Subramanian, indicated that while the plant is operating below margin, it is ramping up production and is on track to contribute positively to the company’s EBITDA in the near future.

Market | 24/11/2025 | By Darshana |  130

Steriline Marks 100th Installation in India as It Returns to CPHI & PMEC

With approximately 20 years of activity in the Indian market, Steriline has now reached 100 full line installations and aims for double-digit annual installations in 2026.

Market | 21/11/2025 | By Dineshwori |  126

Solventum to Acquire Acera Surgical for USD 725 Million to Boost Regenerative Wound Care

Solventum, a healthcare company rooted in decades of innovation, announced a definitive agreement to acquire Acera Surgical for $725 million in cash, with an additional $125 million in milestone-based contingent payments.

Market | 21/11/2025 | By Darshana |  213

Abbott to Acquire Exact Sciences in USD 21 Billion Deal, Entering Cancer Diagnostics Sectors

After the transaction, Exact Sciences—projected to generate more than USD 3 billion in revenue this year with high-teens organic growth—will operate as a subsidiary of Abbott.

Market | 21/11/2025 | By Dineshwori |  177

GSK and LTZ Collaborate to Advance Novel Myeloid Cell Engagers in Oncology

Leveraging LTZ’s novel immune-engager platform and GSK’s oncology expertise, the partnership aims to deliver potent, safer cancer therapies that can be administered in community settings, supporting GSK’s strategy to advance transformative medicines through cutting-edge technologies.

Market | 20/11/2025 | By Dineshwori |  130

EY-OPPI Report Outlines Three-Pronged Strategy to Unlock India's USD 450 Billion Pharma Potential

India’s pharma industry will need to move from a volume-led approach to a model driven by value, innovation and stronger collaboration across the ecosystem if it is to achieve its projected value of USD 450 billion by 2047, says EY–OPPI Report.

Market | 20/11/2025 | By Dineshwori |  366

Thermo Fisher Opens East Coast Collaboration Center for Advanced Therapeutics

Thermo Fisher Scientific has opened a new East Coast Collaboration Center at BioLabs in Philadelphia, offering advanced lab space and expert support to help researchers accelerate the development of cell and gene therapies from early-stage discovery to clinical readiness.

Market | 19/11/2025 | By Dineshwori |  127